Anti-wolbachia pyrido[2,3-d]pyrimidine compounds
US-12545675-B2 · Feb 10, 2026 · US
with hetero atoms directly attached in position 4
with hetero atoms directly attached in position 4 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D239/86 |
| Official title | with hetero atoms directly attached in position 4 |
| Display label | with hetero atoms directly attached in position 4 |
| Total patents | 45 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Bicyclic-fused heteroaryl or aryl compounds
US-12202836-B2 · Jan 21, 2025 · US
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US-12049461-B2 · Jul 30, 2024 · US
DNA-PK inhibitors
US-12005127-B2 · Jun 11, 2024 · US
ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS
US-2023348460-A1 · Nov 2, 2023 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2023339960-A1 · Oct 26, 2023 · US
Bicyclic-fused heteroaryl or aryl compounds
US-11702424-B2 · Jul 18, 2023 · US
Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds
US-11518760-B2 · Dec 6, 2022 · US
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
US-11261199-B2 · Mar 1, 2022 · US
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
US-11230558-B2 · Jan 25, 2022 · US
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US-2021276988-A1 · Sep 9, 2021 · US
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
US-11008341-B2 · May 18, 2021 · US
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US-10882851-B2 · Jan 5, 2021 · US
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
US-10865214-B2 · Dec 15, 2020 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2020377511-A1 · Dec 3, 2020 · US
Dna-pk inhibitors
US-2020353101-A1 · Nov 12, 2020 · US
Bicyclic-fused heteroaryl or aryl compounds
US-10793579-B2 · Oct 6, 2020 · US
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
US-2020216469-A1 · Jul 9, 2020 · US
Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
US-10487091-B2 · Nov 26, 2019 · US
Compounds
US-2019345157-A1 · Nov 14, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D239/86?
- CPC C07D239/86 is the Cooperative Patent Classification code for “with hetero atoms directly attached in position 4.”
- How many patents are filed under CPC C07D239/86 (with hetero atoms directly attached in position 4)?
- Our database includes 45 publications tagged with this CPC code.
- Is patent activity under CPC C07D239/86 growing?
- Publication counts under this code: 2 in 2024 vs 1 in 2025 (latest complete years).